Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,370.00
(
-0.75%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
103.99
(
-0.40%
)
Bitcoin
76,968.29
(
0.82%
)
News Focus
News Focus
Post# of 257458
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122898
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 109211

Thursday, 11/18/2010 3:47:18 PM

Thursday, November 18, 2010 3:47:18 PM

Post# of 257458

Don't think EXEL would be used for bone-mets-prevention, rather treat those who have developed bone mets already.

Treatment of bone mets is precisely the indication for which Denosumab has a PDUFA date today—see the first group of rows in #msg-51295923.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today